Comprehensive Blood & Cancer Center

Comprehensive Blood & Cancer Center specializes in providing vital cancer treatment services and diagnostic screenings, focusing on oncology and advanced medical devices to improve patient care. Founded in 1984 and headquartered in Bakersfield, US, Comprehensive Blood & Cancer Center (CBCC) delivers specialized oncology services. The firm has not undergone any notable pivots in business strategy. Lynda Beaton serves as the CEO, leading the center's dedicated efforts in cancer care.

CBCC primarily offers a range of cancer treatment services and diagnostic screenings, specializing in oncology, neuropsychiatry, and medical devices. Their core service includes free low-dose CT lung cancer screenings for qualifying individuals aged 50 and above with a history of heavy smoking. This program aims to identify lung cancer at its earliest stages, addressing a significant health issue in the community. Additionally, CBCC's Global Research department is involved in clinical trials across various cancer fields, enhancing access to the latest treatments for patients.

The center collaborates closely with prestigious institutions, including UCLA and Dignity Health, to provide advanced technology and treatment options. CBCC serves a diverse patient base throughout the Central Valley and beyond, extending its clinical trial services and advanced cancer care to various geographical markets, including areas in the United States and India. The revenue structure at CBCC is generated from various service offerings, primarily through direct patient services and clinical trials. Patients typically engage with the center for routine screenings, chemotherapy, and other oncology treatments, contributing to a transactional model based on patient interactions.

The revenue model reflects a direct-to-consumer approach, where patients access services like low-dose CT scans and cancer treatments either through insurance coverage or self-pay arrangements. The center's partnership with entities like the UCLA Jonsson Comprehensive Cancer Center enhances its capabilities, allowing participation in clinical trials that may attract additional funding or grants. The comprehensive cancer care services, along with their clinical research initiatives, position CBCC as a pivotal provider in the healthcare landscape, driving revenue through essential oncology services and innovative research programs.